In addition to the agenda items mentioned in our board meeting notice dated 18.05.2025, the following agenda item will also be considered at the meeting scheduled on 27.05.2026. 1. To ....
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bal Pharma Limited has issued an addendum to its previously announced board meeting scheduled for 27.05.2026. The addendum reveals one additional agenda item: the board will consider and approve a proposal for fund raising through preferential issue of warrants to promoters. This means existing promoters would receive warrants that can be converted into equity shares at a later date, typically at a predetermined price. The company has not disclosed the specific size of the fund raise or the proposed conversion price in this intimation. All other agenda items from the original notice dated 18.05.2026 remain unchanged.
This announcement signals potential equity dilution as promoters may receive warrants at preferential terms. The market typically views such issuances cautiously due to dilution concerns, though the actual impact will depend on the pricing and terms of the warrants once approved.